What is the normal flow of a biopharmaceutical product? How might it differ in an emergency?
There is no single answer to this question. Given the innumerable routes and checkpoints that medications move through the supply chain to a patient’s medicine cabinet (from the sourcing of raw materials to the packaging of manufactured drugs), potential disruptions can occur at any point along this chain. For more information, visit the “Normal Biopharmaceutical Supply System” main page.
